HEMOGENYX PHARMPLC Financials
| 5HU Stock | EUR 4.14 0.62 13.03% |
HEMOGENYX |
Understanding current and past HEMOGENYX PHARMPLC Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of HEMOGENYX PHARMPLC's financial statements are interrelated, with each one affecting the others. For example, an increase in HEMOGENYX PHARMPLC's assets may result in an increase in income on the income statement.
HEMOGENYX PHARMPLC Stock Summary
HEMOGENYX PHARMPLC competes with Moderna, Superior Plus, SIVERS SEMICONDUCTORS, NorAm Drilling, and Norsk Hydro. Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was incorporated in 2013 and is headquartered in London, the United Kingdom. HEMOGENYX PHARM is traded on Frankfurt Stock Exchange in Germany.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | GB00BYX3WZ24 |
| Business Address | 5 Fleet Place |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.hemogenyx.com |
| Phone | 44 79 0917 7311 |
| Currency | EUR - Euro |
You should never invest in HEMOGENYX PHARMPLC without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of HEMOGENYX Stock, because this is throwing your money away. Analyzing the key information contained in HEMOGENYX PHARMPLC's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
HEMOGENYX PHARMPLC Key Financial Ratios
There are many critical financial ratios that HEMOGENYX PHARMPLC's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that HEMOGENYX PHARMPLC reports annually and quarterly.HEMOGENYX Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining HEMOGENYX PHARMPLC's current stock value. Our valuation model uses many indicators to compare HEMOGENYX PHARMPLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HEMOGENYX PHARMPLC competition to find correlations between indicators driving HEMOGENYX PHARMPLC's intrinsic value. More Info.HEMOGENYX PHARMPLC LS 01 is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HEMOGENYX PHARMPLC's earnings, one of the primary drivers of an investment's value.HEMOGENYX PHARMPLC Systematic Risk
HEMOGENYX PHARMPLC's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. HEMOGENYX PHARMPLC volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on HEMOGENYX PHARMPLC correlated with the market. If Beta is less than 0 HEMOGENYX PHARMPLC generally moves in the opposite direction as compared to the market. If HEMOGENYX PHARMPLC Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one HEMOGENYX PHARMPLC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of HEMOGENYX PHARMPLC is generally in the same direction as the market. If Beta > 1 HEMOGENYX PHARMPLC moves generally in the same direction as, but more than the movement of the benchmark.
HEMOGENYX PHARMPLC December 18, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of HEMOGENYX PHARMPLC help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of HEMOGENYX PHARMPLC LS 01. We use our internally-developed statistical techniques to arrive at the intrinsic value of HEMOGENYX PHARMPLC LS 01 based on widely used predictive technical indicators. In general, we focus on analyzing HEMOGENYX Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build HEMOGENYX PHARMPLC's daily price indicators and compare them against related drivers.
| Downside Deviation | 23.24 | |||
| Information Ratio | 0.1241 | |||
| Maximum Drawdown | 2233.33 | |||
| Value At Risk | (26.32) | |||
| Potential Upside | 35.71 |
Complementary Tools for HEMOGENYX Stock analysis
When running HEMOGENYX PHARMPLC's price analysis, check to measure HEMOGENYX PHARMPLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HEMOGENYX PHARMPLC is operating at the current time. Most of HEMOGENYX PHARMPLC's value examination focuses on studying past and present price action to predict the probability of HEMOGENYX PHARMPLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HEMOGENYX PHARMPLC's price. Additionally, you may evaluate how the addition of HEMOGENYX PHARMPLC to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |